Lopinavir

Results: 160



#Item
1011  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for INTELENCE®.

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for INTELENCE®.

Add to Reading List

Source URL: www.intelence.com

Language: English - Date: 2014-08-26 13:35:32
102The Institute for Safe Medication Practices Canada (ISMP Canada) is an independent national nonprofit agency established for the collection and analysis of medication error reports and the development of recommendations

The Institute for Safe Medication Practices Canada (ISMP Canada) is an independent national nonprofit agency established for the collection and analysis of medication error reports and the development of recommendations

Add to Reading List

Source URL: www.ismp-canada.org

Language: English - Date: 2009-08-07 11:27:39
103GlaxoSmithKline PO Box[removed]Five Moore Drive Research Triangle Park North Carolina[removed]www.gsk.com

GlaxoSmithKline PO Box[removed]Five Moore Drive Research Triangle Park North Carolina[removed]www.gsk.com

Add to Reading List

Source URL: www.fda.gov

Language: English
104Information Record: HIV Post-exposure Prophylaxis Complete this form for EACH individual receiving Post-exposure Prophylaxis (PEP) for HIV PLEASE PRINT CLEARLY Exposed Name OR HIV Non-nominal Code: ______________________

Information Record: HIV Post-exposure Prophylaxis Complete this form for EACH individual receiving Post-exposure Prophylaxis (PEP) for HIV PLEASE PRINT CLEARLY Exposed Name OR HIV Non-nominal Code: ______________________

Add to Reading List

Source URL: www.gov.mb.ca

Language: English - Date: 2009-09-01 11:26:42
105Manitoba Health and Healthy Living HIV Post-exposure Prophylaxis Drug Order Form Fax order to: Taché Pharmacy Fax: [removed]Phone: [removed]Please note that inquiries (not orders) can be sent to: [removed]

Manitoba Health and Healthy Living HIV Post-exposure Prophylaxis Drug Order Form Fax order to: Taché Pharmacy Fax: [removed]Phone: [removed]Please note that inquiries (not orders) can be sent to: [removed]

Add to Reading List

Source URL: www.gov.mb.ca

Language: English - Date: 2009-09-01 11:26:42
106HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tabl

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tabl

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-02-22 15:55:21
107HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tabl

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tabl

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-03-04 08:24:32
108HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NORVIR safely and effectively. See full prescribing information for NORVIR. NORVIR (ritonavir) Tablet for Oral use N

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NORVIR safely and effectively. See full prescribing information for NORVIR. NORVIR (ritonavir) Tablet for Oral use N

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-11-26 16:16:36
109HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APTIVUS safely and effectively. See full prescribing information for APTIVUS. APTIVUS® (tipranavir) capsules APTIVU

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APTIVUS safely and effectively. See full prescribing information for APTIVUS. APTIVUS® (tipranavir) capsules APTIVU

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-08 13:54:36
110IMMEDIATE ATTENTION REQUIRED DISPENSING ERROR ALERT Dear Healthcare Professional, Medication dispensing errors are a serious threat to quality healthcare and necessitate the combined efforts of all involved to minimize t

IMMEDIATE ATTENTION REQUIRED DISPENSING ERROR ALERT Dear Healthcare Professional, Medication dispensing errors are a serious threat to quality healthcare and necessitate the combined efforts of all involved to minimize t

Add to Reading List

Source URL: www.fda.gov

Language: English